Cross-Species Translation Enhances the Use of Mouse Models for Translatability and Drug Discovery in Late-Onset Alzheimer's Disease
This study introduces the TransComp-R computational framework to bridge transcriptomic gaps between mouse models and human late-onset Alzheimer's disease, successfully identifying and validating the orexin receptor antagonist suvorexant as a repurposable drug that reduces phosphorylated tau levels in human patients.